Rocio Salas-Whalen

Join Dr. Rocio Salas-Whalen, a triple board certified endocrinologist, as she dives into the complexities of obesity and weight loss treatments. They discuss the truth about GLP-1 medications like Ozempic, including their effects on appetite and cravings. Dr. Salas-Whalen emphasizes that obesity isn't a personal failure and explains the five causes of weight gain, many of which are beyond individual control. She also shares her personal experiences with weight management during perimenopause, offering insights for women navigating similar challenges.

Dr. Rocio Salas-Whalen, a triple board-certified endocrinologist and obesity medicine expert, shares her insights on the groundbreaking GLP-1 therapies. She discusses how these medications can combat obesity, reduce inflammation, and potentially lower Alzheimer's and cancer risks. Dr. Salas-Whalen also explores the connection between estrogen, menopause, and weight gain, emphasizing a shift in patient goals from appearance to strength. Tune in for her take on the future of GLP-1 innovations and her upcoming book, 'Weightless.'

Dr. Rocio Salas-Whalen, a triple board-certified internist and founder of New York Endocrinology, joins the conversation to discuss GLP-1 medications and their impact on midlife women. She explains how these drugs redefine obesity treatment as a chronic condition influenced by hormones and metabolism. The discussion dives into why estrogen decline leads to weight gain and abdominal fat, how GLP-1s can help, and the significance of preserving muscle mass during weight loss. Dr. Salas-Whalen also introduces her GPS protocol, combining GLP-1s with protein and strength training.

Dr. Rocio Salas-Whalen discusses the science behind Ozempic injections for weight loss. They explore the use of FDA-approved medications for weight loss, the benefits of weight loss maintenance medication, and the side effects and risks associated with these medications. They also touch on the concerns of off-label usage, the need for FDA regulation of supplements, and the importance of prioritizing patient health.

Dr. Rocio Salas-Whalen, owner of New York Endocrinology and a renowned expert in diabetes and obesity, dives into the evolving understanding of obesity as a chronic disease. She discusses its complex ties to type 2 diabetes and the rising awareness post-COVID-19. The conversation highlights groundbreaking GLP-1 and GIP medications that reshape the weight loss landscape, discussing their benefits and psychological impacts on food cravings. Dr. Salas-Whalen also addresses the challenges posed by insurance companies in treating obesity, pushing for a more proactive medical approach.

Dr. Rocio Salas-Whalen, a board-certified endocrinologist and obesity medicine specialist, delves into the surprising benefits of GLP-1 medications beyond appetite suppression. She discusses their impact on fertility, inflammation, and even addictive behaviors, reshaping our understanding of metabolic and hormonal health. Dr. Salas-Whalen emphasizes the importance of body composition over BMI and shares insights on how muscle serves as an anti-inflammatory powerhouse. Get ready for a mind-opening conversation on holistic health and the future of weight management!

Dr. Rocio Salas-Whalen, a triple board-certified endocrinologist and founder of New York Endocrinology, shares insights into the effects of GLP-1 medications on weight loss and menopause. She highlights the overlooked mental and physical changes post-weight loss and emphasizes the importance of the maintenance phase. Dr. Salas-Whalen also discusses the cost crisis surrounding GLP-1s, the psychological impacts of rapid weight loss, and the necessity of therapy for emotional support. Her expertise includes handling emerging treatments and ensuring effective patient care.

In this engaging discussion, Dr. Rocio Salas-Whalen, an obesity and metabolic health specialist, dives into the complexities of GLP-1 medications. She explains how these drugs go beyond weight loss, highlighting their roles in reducing cancer and Alzheimer’s risk through anti-inflammatory properties. Dr. Salas-Whalen also discusses how menopause affects fat gain and the potential of combining hormone replacement therapy with GLP-1s. Plus, she debunks myths around willpower and obesity, emphasizing the genetic factors at play.

Dr. Rocio Salas-Whalen, a triple board certified physician specializing in obesity and endocrinology, shares insightful perspectives on obesity and pharmacological treatments for women. She explores the role of GLP-1 agonists like Ozempic in weight management, discussing their mechanisms and effects on appetite. The conversation also covers hormonal impacts during perimenopause and menopause, the complexity of weight loss influenced by genetics and lifestyle, and the potential benefits of testosterone therapy. Tune in for myth-busting revelations and expert advice!

Dr. Rocio Salas-Whalen, the top specialist in Ozempic and related weight loss medications, discusses the safety of Ozempic, the US obesity epidemic, dangers of rapid weight loss, causes of obesity, and strategies for long-term weight loss. The podcast also explores the mechanisms of Ozempic, the global impact of the obesity epidemic, dangers of misuse, history and availability of weight loss medications, guilt associated with obesity, and the future of weight loss medications.